Drug
S 55746
S 55746: highest development phase Phase 1, developed by Servier. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Servier
Trials
| Drug | Phase | Indication |
|---|---|---|
| S 55746 NCT02920697 | Phase 1 | Chronic Lymphocytic Leukaemia (CLL) |
Latest
No recent events.
Follow S 55746 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.